Your Article Summary
See Latest ArticlesMulticenter, Randomized Study of the Efficacy and Safety of Intravenous Iclaprim in Complicated Skin and Skin Structure Infections
Antimicrobial Agents and Chemotherapy, 06/26/09
Krievins D et al. - Iclaprim exhibited a safety profile similar to that of vancomycin, an established drug for the treatment of cSSSI. Results from this study indicate that iclaprim is a promising new therapy for the treatment of cSSSI, in particular those caused by S. aureus, including MRSA.
Related Articles
In Vitro Bactericidal Activity of Iclaprim in Human Plasma
Antimicrobial Agents and Chemotherapy, 10/09/09
Relevance Score: 87%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Severe atopic dermatitis treated with everolimus
Journal of Dermatological Treatment , 12/07/09
Silver enhances the in vitro antifungal activity of the saponin, CAY-1
Mycoses, 12/07/09
Intensified Inflammatory Reaction of Actinic Keratoses after Single Application of Topical 5-Fluorouracil in a Patient Treated with Nilotinib for Chronic Myeloid Leukemia
Dermatology, 12/07/09
Today in Derm Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Staphylococcal Toxic Shock Syndrome Erythroderma Is Associated with Superantigenicity and Hypersensitivity
Clinical Infectious Diseases, 12/07/09
Tinea incognito in children: 54 cases
Mycoses, 12/07/09
Silver enhances the in vitro antifungal activity of the saponin, CAY-1
Mycoses, 12/07/09